<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jordan Paradise</style></author><author><style face="normal" font="default" size="100%">Susan M. Wolf</style></author><author><style face="normal" font="default" size="100%">Kuzma, Jennifer</style></author><author><style face="normal" font="default" size="100%">Kuzhabekova, Aliya</style></author><author><style face="normal" font="default" size="100%">Tisdale, Alison W.</style></author><author><style face="normal" font="default" size="100%">Kokkoli, Efrosini</style></author><author><style face="normal" font="default" size="100%">Gurumurthy Ramachandran</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences</style></title><secondary-title><style face="normal" font="default" size="100%">The Journal of Law, Medicine &amp; Ethics</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">12/2009</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">37</style></volume><pages><style face="normal" font="default" size="100%">688 - 705</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">This article discusses the oversight issues raised for the United States by the emergence of nanobiotechnology, and what regulatory agencies can learn from looking at five oversight case studies in how to handle these challenges. The cases reviewed include the oversight of genetically modified organisms in the food supply, pharmaceuticals, medical devices, chemicals in the workplace, and gene therapy.</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue></record></records></xml>